EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Revisiting clinical scoring tools for the diagnosis of thrombotic thrombocytopenic purpura (TTP)

Shruti Kharat, Shrimati Shetty, Maushmi S Kumar

Journal of Thrombosis and Thrombolysis · 21.08.2026

DOI: 10.1007/s11239-026-03390-5 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Thrombosis and Thrombolysis, online erschienen am 21.08.2026. Verfasst von Shruti Kharat und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, K.J. Somaiya Hospital & Research Center, Somaiya Ayurvihar, Sion East, Mumbai, India. Die Arbeit nennt 71 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Thrombotic thrombocytopenic purpura (TTP) is a rare, life-threatening hematologic emergency that leads to increased complexities and mortality due to diagnostic delays. Therapeutic plasma exchange (TPE) along with immunosuppressants is life-saving in cases with severe ADAMTS13 deficiency. Routine ADAMTS13 activity testing is unavailable in many diagnostic centers. Clinical heterogeneity also complicates the early differentiation of TTP from TTP-like syndromes. To critically examine the efficacy of contemporary clinical scoring systems used in the prediction of severe ADAMTS13 deficiency and guide early TPE initiation in the absence of ADAMTS13 activity testing. A literature search was made in PubMed, Embase, Scopus, and Cochrane Library databases from inception till December 2025. Only those studies evaluating PLASMIC, French, and Bentley scores in comparison with standard ADAMTS13 activity assays were included. Existing clinical scoring tools demonstrate high sensitivity in selected cohorts; their real-world utility is limited by modest specificity, population-dependent variability, and misclassification in complex clinical settings such as critical illness, pregnancy, malignancy, renal dysfunction, and old age. Clinical scoring systems facilitate early decision-making, but insufficient as stand-alone diagnostic tools. Overestimation of TTP risk may lead to unnecessary TPE exposure and increased healthcare cost. Emerging strategies, including rapid ADAMTS13 assays, biomarkers, and machine-learning approaches, may permit early TTP diagnosis and prompt management.

Schlagwörter

Stichwörter der Autor:innen

ADAMTS13 activityBentley scoreClinical scoring toolsFrench scorePLASMIC scoreThrombotic microangiopathyThrombotic thrombocytopenic purpura

Autor:innen und Institutionen

  • Department of Hematology, K.J. Somaiya Hospital & Research Center, Somaiya Ayurvihar, Sion East, Mumbai, India.
  • Somaiya Institute for Research and Consultancy (SIRAC), Somaiya Vidyavihar University, Vidyavihar (East), 400077, Mumbai, India.
  • Somaiya Institute for Research and Consultancy (SIRAC), Somaiya Vidyavihar University, Vidyavihar (East), 400077, Mumbai, India. maushmi@somaiya.edu.

Zitieren

APA

Kharat, S., Shetty, S., & Kumar, M. S. (2026). Revisiting clinical scoring tools for the diagnosis of thrombotic thrombocytopenic purpura (TTP). Journal of Thrombosis and Thrombolysis. https://doi.org/10.1007/s11239-026-03390-5

Vancouver

Kharat S, Shetty S, Kumar MS. Revisiting clinical scoring tools for the diagnosis of thrombotic thrombocytopenic purpura (TTP). Journal of Thrombosis and Thrombolysis. 2026. doi:10.1007/s11239-026-03390-5

BibTeX
@article{Kharat2026,
  author = {Kharat, Shruti and Shetty, Shrimati and Kumar, Maushmi S},
  title = {Revisiting clinical scoring tools for the diagnosis of thrombotic thrombocytopenic purpura (TTP)},
  journal = {Journal of Thrombosis and Thrombolysis},
  year = {2026},
  doi = {10.1007/s11239-026-03390-5}
}
Kostenlos starten →